Ron Recce

Statistics

Publications

Citations

270

H-Index

Active since

1995

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Ron Recce is an author at Bristol-Myers Squibb (United States) specializing in atherosclerosis molecular mechanisms, cardiovascular disease, and inflammation.

Publications per year

1995–2000

Publications

Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol.

Mark C. Kowala, Patricia M. Rose, Philip D. Stein et al. · PubMed · 1995 · 127 citations

Veterinary Medicine, Pharmacology, Physiology +15

Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE

Mark C. Kowala, Ron Recce, Sophie Beyer et al. · Atherosclerosis · 2000 · 83 citations

Life Sciences, Immunology, Physiology +17

Enhanced Reduction of Atherosclerosis in Hamsters Treated with Pravastatin and Captopril: ACE in Atheromas Provides Cellular Targets for Captopril

Mark C. Kowala, Maria Valentine, Ron Recce et al. · Journal of Cardiovascular Pharmacology · 1998 · 38 citations

Medicine, Pharmacology, Pharmacotherapy +17

Regression of Early Atherosclerosis in Hyperlipidemic Hamsters Induced by Fosinopril and Captopril

Mark C. Kowala, Ron Recce, Sophie Beyer et al. · Journal of Cardiovascular Pharmacology · 1995 · 22 citations

Pharmacy, Animal Sciences, Cardiology +14

1–4 of 4